Science

The University of Texas has published over 11 papers on the Imprex SFL technology. In 2003, UT Austin was nominated for Invention of the Year by Elsevier Sciences for Imprex SFL. Three posters were presented at the recent AAPS conference in 2003 confirming the distinct advantages of Imprex SFL over competitive lyophilization and spray freeze drying techniques. Bottom line: protein structures are preserved and long-term stability is enhanced. And with the FDA forcing biopharma to meet or exceed label claims and discussing the possibility of future aggregation limits, biopharma cannot afford to let this stability technology pass them by.